A Phase III Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/ Influsplit SSW [influenza virus vaccine] 2008/2009 in People Aged 18 Years or Above.

Trial Profile

A Phase III Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/ Influsplit SSW [influenza virus vaccine] 2008/2009 in People Aged 18 Years or Above.

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Dec 2016

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 04 Aug 2008 Status changed from recruiting to completed according to ClinicalTrials.gov.
    • 02 Aug 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top